Variation in neutrophil to lymphocyte ratio (NLR) as predictor of outcomes in metastatic renal cell carcinoma (mRCC) and non-small cell lung cancer (mNSCLC) patients treated with nivolumab
Titel:
Variation in neutrophil to lymphocyte ratio (NLR) as predictor of outcomes in metastatic renal cell carcinoma (mRCC) and non-small cell lung cancer (mNSCLC) patients treated with nivolumab
Auteur:
Simonaggio, A. Elaidi, R. Fournier, L. Fabre, E. Ferrari, V. Borchiellini, D. Thouvenin, J. Barthelemy, P. Thibault, C. Tartour, E. Oudard, S. Vano, Y. A.